Published in Am J Trop Med Hyg on April 01, 2010
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med (1996) 5.07
Efficacy of an acellular pertussis vaccine among adolescents and adults. N Engl J Med (2005) 3.21
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology (1992) 3.03
Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc Natl Acad Sci U S A (1991) 2.49
Resurgence of pertussis in Europe. Pediatr Infect Dis J (2005) 2.23
Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J (2005) 2.06
Epidemiology of pertussis. Pediatr Infect Dis J (2005) 1.84
Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine (2006) 1.65
Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study. J Infect Dis (2004) 1.60
What is new in pertussis? Eur J Pediatr (2007) 1.52
Pertussis: current concepts of pathogenesis and prevention. Pediatr Infect Dis J (1997) 1.41
Epidemiology of pertussis. Pediatr Infect Dis J (2006) 1.13
Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine (2001) 1.08
Adolescent and adult pertussis: disease burden and prevention. Curr Opin Pediatr (2006) 0.96
Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine (2000) 0.94
Antibody and cell-mediated immune responses to booster immunization with a new acellular pertussis vaccine in school children. Vaccine (1998) 0.86
Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine. Vaccine (2005) 0.82
Tetracycline protects against dermonecrosis induced by Loxosceles spider venom. J Invest Dermatol (2007) 1.50
Early transplantation of human immature dental pulp stem cells from baby teeth to golden retriever muscular dystrophy (GRMD) dogs: Local or systemic? J Transl Med (2008) 1.38
Spider and bacterial sphingomyelinases D target cellular lysophosphatidic acid receptors by hydrolyzing lysophosphatidylcholine. J Biol Chem (2004) 1.33
IgY: a promising antibody for use in immunodiagnostic and in immunotherapy. Vet Immunol Immunopathol (2010) 1.25
Structural basis for metal ion coordination and the catalytic mechanism of sphingomyelinases D. J Biol Chem (2005) 1.15
Antileishmanial and antitrypanosomal activity of bufadienolides isolated from the toad Rhinella jimi parotoid macrogland secretion. Toxicon (2008) 1.13
Transcriptome analysis of Loxosceles laeta (Araneae, Sicariidae) spider venomous gland using expressed sequence tags. BMC Genomics (2008) 1.03
Molecular cloning and expression of a functional dermonecrotic and haemolytic factor from Loxosceles laeta venom. Biochem Biophys Res Commun (2002) 1.01
Structural insights into the catalytic mechanism of sphingomyelinases D and evolutionary relationship to glycerophosphodiester phosphodiesterases. Biochem Biophys Res Commun (2006) 1.00
Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1. Proc Natl Acad Sci U S A (2005) 0.99
Diversity of Micrurus snake species related to their venom toxic effects and the prospective of antivenom neutralization. PLoS Negl Trop Dis (2010) 0.96
Cryptides: buried secrets in proteins. Peptides (2007) 0.93
Immunological parameters related to the adjuvant effect of the ordered mesoporous silica SBA-15. Vaccine (2010) 0.92
Paracoccin, an N-acetyl-glucosamine-binding lectin of Paracoccidioides brasiliensis, is involved in fungal growth. Microbes Infect (2007) 0.92
B-lymphocytes in bone marrow or lymph nodes can take up plasmid DNA after intramuscular delivery. Hum Gene Ther (2003) 0.92
Mast cells modulate pulmonary acute inflammation and host defense in a murine model of tuberculosis. J Infect Dis (2007) 0.92
Management of dry eye related to systemic diseases in childhood and longterm follow-up. Acta Ophthalmol Scand (2007) 0.91
Argininosuccinate synthetase is a functional target for a snake venom anti-hypertensive peptide: role in arginine and nitric oxide production. J Biol Chem (2009) 0.91
Human complement activation and anaphylatoxins generation induced by snake venom toxins from Bothrops genus. Mol Immunol (2010) 0.91
SMase II, a new sphingomyelinase D from Loxosceles laeta venom gland: molecular cloning, expression, function and structural analysis. Toxicon (2009) 0.90
Mycobacterium hsp65 DNA entrapped into TDM-loaded PLGA microspheres induces protection in mice against Leishmania (Leishmania) major infection. Parasitol Res (2006) 0.90
Effect of bioactive peptides isolated from yeastolate, lactalbumin and NZCase in the insect cell growth. Bioprocess Biosyst Eng (2007) 0.89
Host genetic background affects regulatory T-cell activity that influences the magnitude of cellular immune response against Mycobacterium tuberculosis. Immunol Cell Biol (2010) 0.89
Variations in Loxosceles spider venom composition and toxicity contribute to the severity of envenomation. Toxicon (2005) 0.89
The immune response to toxocariasis does not modify susceptibility to Mycobacterium tuberculosis infection in BALB/c mice. Am J Trop Med Hyg (2007) 0.88
Dietary restriction abrogates antibody production induced by a DNA vaccine encoding the mycobacterial 65 kDa heat shock protein. Genet Vaccines Ther (2009) 0.88
Experimental tuberculosis: designing a better model to test vaccines against tuberculosis. Tuberculosis (Edinb) (2010) 0.87
Interspecific variation in venom composition and toxicity of Brazilian snakes from Bothrops genus. Toxicon (2008) 0.87
Loxosceles spider venom induces metalloproteinase mediated cleavage of MCP/CD46 and MHCI and induces protection against C-mediated lysis. Immunology (2002) 0.86
Interactions between the NO-citrulline cycle and brain-derived neurotrophic factor in differentiation of neural stem cells. J Biol Chem (2012) 0.86
Micrurus snake venoms activate human complement system and generate anaphylatoxins. BMC Immunol (2012) 0.86
Immunization with pVAXhsp65 decreases inflammation and modulates immune response in experimental encephalomyelitis. Neuroimmunomodulation (2010) 0.85
Immunomodulatory effects of the Tityus serrulatus venom on murine macrophage functions in vitro. Mediators Inflamm (2005) 0.85
Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection. Immunology (2007) 0.84
Purification of a phospholipase A2 from Lonomia obliqua caterpillar bristle extract. Biochem Biophys Res Commun (2006) 0.84
Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention. J Drug Target (2004) 0.84
Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response. Small (2006) 0.84
DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice. J Mol Cell Cardiol (2005) 0.83
Role of matrix metalloproteinases in HaCaT keratinocytes apoptosis induced by loxosceles venom sphingomyelinase D. J Invest Dermatol (2006) 0.83
Enzymatic profiling of tetanus and botulinum neurotoxins based on vesicle-associated-membrane protein derived fluorogenic substrates. Protein Pept Lett (2008) 0.83
Kinetic and mechanistic characterization of the Sphingomyelinases D from Loxosceles intermedia spider venom. Toxicon (2006) 0.83
Comparative analysis of a Bordetella pertussis patient isolated strain and classical strains used in the pertussis vaccine. Vaccine (2005) 0.82
C5a receptor is cleaved by metalloproteases induced by sphingomyelinase D from Loxosceles spider venom. Immunobiology (2012) 0.82
Enzymatic properties of venoms from Brazilian scorpions of Tityus genus and the neutralisation potential of therapeutical antivenoms. Toxicon (2013) 0.82
Biochemical and pharmacological aspects of two bradykinin-potentiating peptides obtained from tryptic hydrolysis of casein. J Protein Chem (2003) 0.81
Premolis semirufa (Walker, 1856) envenomation, disease affecting rubber tappers of the Amazon: searching for caterpillar-bristles toxic components. PLoS Negl Trop Dis (2012) 0.81
A Mycobacterium leprae Hsp65 mutant as a candidate for mitigating lupus aggravation in mice. PLoS One (2011) 0.81
Enhancement of the citrulline-nitric oxide cycle in astroglioma cells by the proline-rich peptide-10c from Bothrops jararaca venom. Brain Res (2010) 0.81
A new anti-loxoscelic serum produced against recombinant sphingomyelinase D: results of preclinical trials. Am J Trop Med Hyg (2008) 0.81
Mechanism of neutrophil dysfunction: neutrophil serine proteases cleave and inactivate the C5a receptor. J Immunol (2014) 0.81
Phenotypic and functional characterization of pulmonary macrophages subpopulations after intratracheal injection of Paracoccidioides brasiliensis cell wall components. Immunobiology (2010) 0.81
Venom of the Brazilian spider Sicarius ornatus (Araneae, Sicariidae) contains active sphingomyelinase D: potential for toxicity after envenomation. PLoS Negl Trop Dis (2013) 0.81
Administration of M. leprae Hsp65 interferes with the murine lupus progression. PLoS One (2008) 0.81
BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis. Clin Dev Immunol (2013) 0.81
Evaluation of a diphtheria and tetanus PLGA microencapsulated vaccine formulation without stabilizers. Curr Drug Deliv (2009) 0.80
Antimycobacterial brominated metabolites from two species of marine sponges. Planta Med (2006) 0.80
Protection conferred by heterologous vaccination against tuberculosis is dependent on the ratio of CD4(+) /CD4(+) Foxp3(+) cells. Immunology (2012) 0.79
Characterization of phenotypes of immune cells and cytokines associated with chronic exposure to Premolis semirufa caterpillar bristles extract. PLoS One (2013) 0.79
Influence of a DNA-hsp65 vaccine on bleomycin-induced lung injury. J Bras Pneumol (2008) 0.79
Central effects of Tityus serrulatus and Tityus bahiensis scorpion venoms after intraperitoneal injection in rats. Neurosci Lett (2009) 0.78
Outer membrane vesicles (OMV) production of Neisseria meningitidis serogroup B in batch process. Vaccine (2012) 0.78
The central nervous system as target for antihypertensive actions of a proline-rich peptide from Bothrops jararaca venom. Cytometry A (2010) 0.78
Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection. BMC Infect Dis (2014) 0.78
DNA-hsp65 vaccine as therapeutic strategy to treat experimental chromoblastomycosis caused by Fonsecaea pedrosoi. Mycopathologia (2012) 0.78
Caissarolysin I (Bcs I), a new hemolytic toxin from the Brazilian sea anemone Bunodosoma caissarum: purification and biological characterization. Biochim Biophys Acta (2006) 0.78
Neurotoxic effects of fractions isolated from Tityus bahiensis scorpion venom (Perty, 1834). Toxicon (2002) 0.78
TGF-beta and CD23 are involved in nitric oxide production by pulmonary macrophages activated by beta-glucan from Paracoccidioides brasiliensis. Med Microbiol Immunol (2009) 0.77
Selective release of ATP from sympathetic nerves of rat vas deferens by the toxin TsTX-I from Brazilian scorpion Tityus serrulatus. Br J Pharmacol (2005) 0.77
The humoral immune response induced by snake venom toxins. Inflamm Allergy Drug Targets (2011) 0.77
Development of an operational synaptobrevin-based fluorescent substrate for tetanus neurotoxin quantification. Biotechnol Appl Biochem (2002) 0.77
A natural carrier effect and the generation of specific antibodies to biologically active peptides. Anal Biochem (2006) 0.77
Self-proteolysis regulation in the Bothrops jararaca venom: the metallopeptidases and their intrinsic peptidic inhibitor. Comp Biochem Physiol C Toxicol Pharmacol (2008) 0.77
Promiscuous and reversible blocker of presynaptic calcium channels in frog and crayfish neuromuscular junctions from Phoneutria nigriventer spider venom. J Neurophysiol (2003) 0.77
Analysis of the toxic potential of venom from Loxosceles adelaida, a Brazilian brown spider from karstic areas. Toxicon (2005) 0.76
TsTx toxin isolated from Tityus serrulatus scorpion venom induces spontaneous recurrent seizures and mossy fiber sprouting. Epilepsia (2003) 0.76
P-I snake venom metalloproteinase is able to activate the complement system by direct cleavage of central components of the cascade. PLoS Negl Trop Dis (2013) 0.76
Ctenus medius and Phoneutria nigriventer spiders venoms share noxious proinflammatory activities. J Med Entomol (2009) 0.76
A microdialysis study of glutamate concentration in the hippocampus of rats after TsTX toxin injection and blockade of toxin effects by glutamate receptor antagonists. Pharmacol Biochem Behav (2003) 0.76
Effects of a toxin isolated from Tityus bahiensis scorpion venom on the hippocampus of rats. Life Sci (2012) 0.76
Investigation of the role of complement and complement receptors in the modulation of B cell activation by a Paracoccidioides brasiliensis cell wall fraction. Clin Immunol (2005) 0.75
Anticomplementary activity of horse IgG and F(ab')2 antivenoms. Am J Trop Med Hyg (2014) 0.75
Comment on "Preclinical assessment of the neutralizing capacity of antivenoms produced in six Latin American countries against medically-relevant Bothrops snake venoms". Toxicon (2011) 0.75
Bothrops jararaca peptide with anti-hypertensive action normalizes endothelium dysfunction involved in physiopathology of preeclampsia. PLoS One (2011) 0.75
TSII toxin isolated from Tityus serrulatus scorpion venom: behavioral, electroencephalographic, and histopathologic studies. Brain Res Bull (2003) 0.75
Lipopolysaccharide as an antigen target for the formulation of a universal vaccine against Escherichia coli O111 strains. Clin Vaccine Immunol (2010) 0.75
Structure activity relationship, acute toxicity and cytotoxicity of antimycobacterial neolignan analogues. J Pharm Pharmacol (2011) 0.75
Effectiveness, against tuberculosis, of pseudo-ternary complexes: peptide-DNA-cationic liposome. J Colloid Interface Sci (2011) 0.75
A rational design for the nanoencapsulation of poisonous animal venoms in liposomes prepared with natural phospholipids. Curr Drug Deliv (2012) 0.75
Regional brain c-fos activation associated with penile erection and other symptoms induced by the spider toxin Tx2-6. Toxicon (2011) 0.75
Characterization of a new muscarinic toxin from the venom of the Brazilian coral snake Micrurus lemniscatus in rat hippocampus. Life Sci (2011) 0.75
Analysis of secreted protein profile and enzymatic activities from Corynebacterium diphtheriae and Bordetella pertussis on production batch media using peptide quenched fluorescent substrates. Prep Biochem Biotechnol (2007) 0.75
Dantrolene protects hippocampal cells from damage induced by TsTX, an alpha-scorpion toxin from Tityus serrulatus. Toxicon (2004) 0.75
Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3. Immunobiology (2003) 0.75
Intrahippocampal injection of TsTX-I, a beta-scorpion toxin, causes alterations in electroencephalographic recording and behavior in rats. Life Sci (2010) 0.75
A universal polysaccharide conjugated vaccine against O111 E. coli. Hum Vaccin Immunother (2014) 0.75